THE SINGLE BEST STRATEGY TO USE FOR TRASTUZUMAB PACKAGE INSERT

In July 2024, the CHMP adopted a beneficial view, recommending the granting of a marketing authorization for that medicinal product or service Tuznue, supposed with the therapy of breast and gastric cancer.The authors declare the exploration was done within the absence of any business or money interactions which could be construed as a possible con